1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Mp0420: new trials by email Literature Review of Mp0420 trials Research Report on Mp0420
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19 ensovibep, Placebo - COVID-19 | Phase 2 / Phase 3 | Terminated | Novartis Pharmaceuticals | 407 | 2021-05-10 | 2026-01-27 |
COVID-19 (1)
Hungary (1) · India (1) · Netherlands (1) · South Africa (1) · United States (1)